MDH1-IN-1 (Compound 5i) is a potent inhibitor of MDH1 with an IC50 of 6.79 μM. MDH1-IN-1 has the potential for the research of cancer diseases[1].
[1]. Naik R, et al. Metl 3-(3-(4-(2,4,4-Trimetlpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dedrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism. J Med Chem. 2017;60(20):8631-8646.
















